ERYTECH Pharma (NASDAQ:ERYP) Trading Down 4.5%

ERYTECH Pharma S.A. (NASDAQ:ERYP)’s stock price was down 4.5% during trading on Friday . The stock traded as low as $0.49 and last traded at $0.51. Approximately 12,777 shares traded hands during trading, a decline of 86% from the average daily volume of 93,510 shares. The stock had previously closed at $0.53.

ERYTECH Pharma Price Performance

The company has a quick ratio of 3.65, a current ratio of 3.65 and a debt-to-equity ratio of 0.32. The business’s 50-day moving average is $0.62 and its two-hundred day moving average is $0.78.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in ERYTECH Pharma stock. Vanguard Personalized Indexing Management LLC bought a new position in shares of ERYTECH Pharma S.A. (NASDAQ:ERYP) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 95,268 shares of the company’s stock, valued at approximately $107,000. Vanguard Personalized Indexing Management LLC owned about 0.31% of ERYTECH Pharma at the end of the most recent quarter. 1.09% of the stock is owned by institutional investors.

ERYTECH Pharma Company Profile

ERYTECH Pharma SA, a biopharmaceutical company, focus on development of red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. It develops eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients.